Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lonidamine in Symptomatic Benign Prostatic Hyperplasia
NCT00435448Phase 3Terminated
- Sponsor
- Threshold Pharmaceuticals
- Start
- Jun 2005
- Primary completion
- Dec 2006
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of lonidamine in benign prostatic hyperplasia (BPH), sponsored by Threshold Pharmaceuticals. Started Jun 2005; status: terminated.
02
Drugs
lonidamine
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT00435448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00435448.